retatrutide ly3437943 glp-1 gip glucagon receptor agonist LY3437943, a novel triple glucagon, GIP, and for glycemic control and weight loss: From discovery to clinical proof of concept π₯ Retatrutide: Triple-Receptor Metabolic Signalling
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 29 - Sep 3

























